Manufacturers of some weight loss supplements often make unsubstantiated claims about the efficacy and safety of their products
They reduce future cardiovascular events, such as heart attack and stroke. Many patients with congestive heart failure who had failed to lose weight multiple times with other methods succeeded with this treatment, according to Tavakol
Postprandial renal haemodynamic effect of lixisenatide versus once-daily insulin glulisine in type 2 diabetes patients on insulin-glargine: an 8-week, randomised, open-label trial
Key takeaways Health insurance companies may stop covering GLP-1 medications for weight loss due to their rising costs and questions about their necessity
People with type 1 diabetes also need to understand that this is a process, she says
Although long-acting GLP-1 receptor agonists commonly cause nausea, the side effect is typically short-lived, and patients generally tolerate the treatment well